Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Total Debt: 2014-2016

Historic Total Debt for KalVista Pharmaceuticals (KALV) over the last 3 years, with Apr 2016 value amounting to $127,000.

  • KalVista Pharmaceuticals' Total Debt rose 3.84% to $4.7 million in Q1 2016 from the same period last year, while for Mar 2016 it was $4.7 million, marking a year-over-year increase of 3.84%. This contributed to the annual value of $127,000 for FY2016, which is N/A change from last year.
  • KalVista Pharmaceuticals' Total Debt amounted to $127,000 in FY2016, which was down 97.24% from $4.6 million recorded in FY2015.
  • In the past 5 years, KalVista Pharmaceuticals' Total Debt registered a high of $4.6 million during FY2015, and its lowest value of $127,000 during FY2016.
  • Moreover, its 3-year median value for Total Debt was $4.4 million (2014), whereas its average is $3.1 million.
  • Data for KalVista Pharmaceuticals' Total Debt shows a peak YoY grew of 3.92% (in 2015) over the last 5 years.
  • Over the past 3 years, KalVista Pharmaceuticals' Total Debt (Yearly) stood at $4.4 million in 2014, then climbed by 3.92% to $4.6 million in 2015, then reached $127,000 in 2016.